- Global Pharma News & Resources

Humanised Mouse Model Market Forecast to 2032 | By Axenis, Trans Genic, Genoway, Vitalstar Biotechnology

In 2022, the global humanised mouse model market is anticipated to be worth US$ 92.5 million. Throughout the decade 2022 to 2032, the industry is expected to grow at a 5.5% CAGR to reach US$ 167.3 Million. Rising healthcare industry need for more active screening of innovative drug candidates identified to cure a variety of chronic diseases such as cardiovascular disorders, diabetes, and malignancies has remained one of the essential characteristics of expanded research activity in the field of humanised mouse models. In the historical period 2016-2021, the market for humanised mouse models grew at a CAGR of 4.9%.

Request Sample@

The use of genetically modified mice in experimental medical research has resulted in important advancements in disease understanding and human health. The manipulation of the mouse genome has gotten increasingly refined with the introduction of gene targeting and transgenic approaches, as well as recent advances in gene-editing tools. Humans and mice have a great deal of genetic similarity; yet, it is also acknowledged that even minor sequence changes between the two species can have significant functional ramifications for the respective individual gene functions.

In addition, certain genes in humans have been found that do not have orthologous mouse counterparts. Because of this divergence, mouse models are no longer a trustworthy tool for predicting gene function in preclinical research. These genetically “humanised” mice could provide more trustworthy in vivo data on human gene function in normal physiology and disease. As a result, there is considerable interest in producing genetically modified mice that express an orthologous human gene.

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: Ingenious Targeting Laboratory, Axenis S.A.S, Trans Genic Inc., Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc., Genoway S.A., Crown Bioscience Inc., Taconic Biosciences Inc., The Jackson Laboratory, Vitalstar Biotechnology Co. Ltd.


The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

To remain ‘ahead’ of your competitors, Ask a Question@

By model type, the humanized mouse model market can be segmented into,

  • Genetic Humanized Mouse Model
  • Cell-based Humanized Mouse Model
  • CD34
  • PBMC
  • BLT

By application, the humanized mouse model market can be segmented into,

  • Oncology
  • Immunology and Infectious Diseases
  • Neuroscience
  • Toxicology
  • Hematopoiesis
  • Others

 By end user, the humanized mouse model market can be segmented into,

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutions

Full in-depth analysis of the parent market

The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.

Important changes in market dynamics

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets

Buy Now@

Queries Solved

  • What is the size of the overall Humanized Mouse Model Market in the Healthcare Industry and its segments?
  • What are the key segments and sub-segments in the market?
  • What are the key drivers, restraints, opportunities, and challenges of the Humanized Mouse Model Market in the Healthcare Industry, and how they are expected to impact the market?
  • What are the attractive investment opportunities within the Humanized Mouse Model Market in the Healthcare Industry?
  • What is the Humanized Mouse Model Market in the Healthcare Industry size at the regional and country-level?
  • What are the key market players focusing on?
  • What are the strategies for growth adopted by the key players in Humanized Mouse Model Market in the Healthcare Industry?
  • What are the recent trends in Humanized Mouse Model Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?
  • What are the challenges to the Humanized Mouse Model Market in the growth of the Healthcare Industry?
  • What are the key market trends impacting the growth of the Humanized Mouse Model Market in the Healthcare Industry?

Table of Content

  • Executive Summary
  • Market Overview
  • Key Success Factors
  • Global Humanized Mouse Model Market – Pricing Analysis
  • Market Background

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 16-Feb-2023